MTARC1 and metabolic dysfunction-associated steatotic liver disease: A brief report from Luukkonen et al. highlighted that individuals carrying the minor allele of the MTARC1 p.A165T polymorphism are characterized by higher blood phosphatidylcholine levels and decreased parameters of NAFLD severity as compared to carriers of the wild-type MTARC1 genotype [14].